Reuters logo
BRIEF-Recro Pharma reports positive top-line results
November 28, 2016 / 12:27 PM / a year ago

BRIEF-Recro Pharma reports positive top-line results

Nov 28 (Reuters) - Recro Pharma Inc :

* Recro pharma reports positive top-line results from pivotal Phase III clinical trial of IV meloxicam

* Recro Pharma Inc says ten secondary endpoints also met

* Recro Pharma Inc says company estimates filing US NDA in summer 2017

* Recro pharma - IV meloxicam achieves primary endpoint of statistically significant reduction in SPID24 in patients with acute postoperative pain

* Says estimates filing US NDA in summer 2017

* Recro pharma - In trial, IV Meloxicam achieved primary endpoint Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below